|
MCID: ATM010
|
Autoimmune Hemolytic Anemia malady |
|
Sources: 6Disease Ontology, 30NIH Rare Diseases, 44Wikipedia, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Autoimmune hemolytic anemia (AIHA) occurs when your immune system makes antibodies that attack your red blood cells. This causes a drop in the number of red blood cells, leading to hemolytic anemia. Symptoms may include unusual weakness and fatigue with tachycardia and breathing difficulties, jaundice, dark urine and/or splenomegaly. AIHA can be primary (idiopathic) or result from an underlying disease or medication. The condition may develop gradually or occur suddenly. There are two main types of autoimmune hemolytic anemia: warm antibody hemolytic anemia and cold antibody hemolytic anemia. Treatment may include corticosteroids such as prednisone, splenectomy, immunosuppressive drugs and/or blood transfusions.30
MalaCards: Autoimmune Hemolytic Anemia, also known as familial auto-immune hemolytic anemia (subtype), is related to hemolytic anemia and hepatitis. An important gene associated with Autoimmune Hemolytic Anemia is CD59 (CD59 molecule, complement regulatory protein), and among its related pathways are RIG-I-like receptor signaling pathway and OX40 Pathway. The drugs cyclophosphamide and globulin,immune (iv) and the compounds cyclophosphamide and ivig have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, monocytes and t cells, and related mouse phenotypes are renal/urinary system and liver/biliary system. Disease Ontology: An autoimmune disease of blood that is characterized by deficient red blood cells caused by auto-antibodies.6 Wikipedia: Autoimmune hemolytic anemia (or autoimmune haemolytic anaemia; AIHA) occurs when antibodies directed...44 more... |
|
Sources: 6Disease Ontology, 30NIH Rare Diseases, 8DISEASES, 32Novoseek , 43UMLS, 40SNOMED-CT, 19ICD9CM, 27NCIt, 33OMIM, 24MeSH See all sources |
Aliases & Descriptions:
|
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for autoimmune hemolytic anemia Drug clinical trials:Search ClinicalTrials for autoimmune hemolytic anemia Search NIH Clinical Center for autoimmune hemolytic anemia Search CenterWatch for autoimmune hemolytic anemia Inferred drug relations via UMLS/NDF-RT:43 28 cyclophosphamide, globulin,immune (iv) |
|
|
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to autoimmune hemolytic anemia:22Bone marrow, Monocytes, T cells, B cells
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to autoimmune hemolytic anemia:25 (show all 17)
|
|
Sources: 35PubMed See all sources |
Articles related to autoimmune hemolytic anemia:(show all 40)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 20KEGG, 36QIAGEN, 10EMD Millipore, 3Cell Signaling Technology, 41Thomson Reuters, 37R&D Systems See all sources |
Pathways related to autoimmune hemolytic anemia according to GeneDecks:(show all 46)
|
|
Sources: 32Novoseek , 34PharmGKB, 9DrugBank, 18HMDB, 42Tocris Bioscience See all sources |
Compounds related to autoimmune hemolytic anemia according to GeneDecks:(show top 50) (show all 283)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to autoimmune hemolytic anemia according to GeneDecks:
Biological processes related to autoimmune hemolytic anemia according to GeneDecks:(show all 24)
Molecular functions related to autoimmune hemolytic anemia according to GeneDecks:
|
